RocketDNA Ltd. (ASX:RKT)

RocketDNA Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.7	3.86	3.41	2.32	2.25	0.95
Short-Term Investments	0.03	0.03	0.04	0.06	0.05	0.04
Cash & Short-Term Investments	2.73	3.89	3.45	2.38	2.31	1
Cash Growth	53.22%	12.95%	45.04%	3.01%	131.82%	-80.20%
Accounts Receivable	1.86	2.04	0.96	1.08	1.16	1.06
Other Receivables	-	0.41	0.23	0.15	0.17	0.09
Receivables	1.86	2.45	1.19	1.23	1.33	1.16
Inventory	0.38	0.57	0.24	0.06	-	-
Prepaid Expenses	-	0.32	0.24	0.26	0.18	0.26
Other Current Assets	-	-	-	-	0.81	6.54
Total Current Assets	4.97	7.23	5.11	3.93	4.62	8.95
Property, Plant & Equipment	2.75	2.65	1.9	1.69	1.14	0.86
Goodwill	1.01	1.02	0.99	0.96	1.19	1.4
Other Intangible Assets	0.6	0.46	0.34	0.22	-	0.01
Long-Term Deferred Tax Assets	0	0.03	0.01	0.02	0.01	0.1
Other Long-Term Assets	-	-	-	-	0	-
Total Assets	9.33	11.39	8.35	6.81	6.97	11.32

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.63	0.76	0.35	0.29	0.55	0.43
Accrued Expenses	-	0.75	0.56	0.51	0.07	0.04
Short-Term Debt	0.17	0.32	0.2	0.11	0.03	0.37
Current Portion of Leases	0.24	0.31	0.26	0.19	0.12	0.1
Current Income Taxes Payable	0.01	0.17	0.11	0.05	-	-
Current Unearned Revenue	0.13	0.48	0.14	0.15	0.01	0.11
Other Current Liabilities	-	-	-	-	0.31	1.95
Total Current Liabilities	2.18	2.79	1.62	1.3	1.09	3.01
Long-Term Debt	0.33	0.39	0.4	0.2	0.12	0.04
Long-Term Leases	0.65	0.6	0.48	0.68	0.11	0.12
Total Liabilities	3.16	3.79	2.5	2.18	1.32	3.17

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	22.38	21.29	17.14	14.37	13.21	13.21
Retained Earnings	-15.41	-12.77	-9.96	-8.03	-6.5	-4.58
Comprehensive Income & Other	-0.75	-0.65	-1.01	-1.41	-1.11	-0.59
Total Common Equity	6.22	7.86	6.18	4.92	5.59	8.04
Minority Interest	-0.06	-0.26	-0.33	-0.3	0.06	0.12
Shareholders' Equity	6.16	7.61	5.85	4.63	5.65	8.15
Total Liabilities & Equity	9.33	11.39	8.35	6.81	6.97	11.32

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.39	1.62	1.34	1.17	0.38	0.63
Net Cash (Debt)	1.33	2.27	2.11	1.2	1.93	0.37
Net Cash Growth	1665.61%	7.64%	75.37%	-37.61%	424.36%	-91.49%
Net Cash Per Share	0.00	0.00	0.00	0.00	0.00	0.00
Filing Date Shares Outstanding	1,235	1,183	884.75	656.11	511.6	511.6
Total Common Shares Outstanding	1,235	1,182	884.75	652.23	511.6	511.6
Working Capital	2.78	4.44	3.49	2.63	3.53	5.95
Book Value Per Share	0.01	0.01	0.01	0.01	0.01	0.02
Tangible Book Value	4.61	6.39	4.85	3.75	4.39	6.63
Tangible Book Value Per Share	0.00	0.01	0.01	0.01	0.01	0.01
Construction In Progress	-	0.02	0.02	0.02	0.17	0.02

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 3, 2026

Data Sources Report a data error